Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.

Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, Russell V, Waddington JL, O'Callaghan E.

Schizophr Res. 2013 Jan;143(1):138-42. doi: 10.1016/j.schres.2012.10.018. Epub 2012 Nov 24.

PMID:
23187069
2.

[Motivational interviewing for cannabis users with psychotic disorders].

Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P.

Encephale. 2007 Oct;33(5):819-26. French.

PMID:
18357854
3.

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.

Barrowclough C, Marshall M, Gregg L, Fitzsimmons M, Tomenson B, Warburton J, Lobban F.

Psychol Med. 2014 Oct;44(13):2749-61. doi: 10.1017/S0033291714000208. Epub 2014 Mar 5.

PMID:
25065535
4.

Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.

Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH; MiData Consortium.

Psychol Med. 2014 Feb;44(3):499-506. doi: 10.1017/S0033291713000883. Epub 2013 May 24.

PMID:
23701858
5.

Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis.

Hjorthøj CR, Orlovska S, Fohlmann A, Nordentoft M.

Schizophr Res. 2013 Dec;151(1-3):191-6. doi: 10.1016/j.schres.2013.10.014. Epub 2013 Nov 1.

PMID:
24189290
6.

The impact of cannabis use on clinical outcomes in recent onset psychosis.

Barrowclough C, Gregg L, Lobban F, Bucci S, Emsley R.

Schizophr Bull. 2015 Mar;41(2):382-90. doi: 10.1093/schbul/sbu095. Epub 2014 Jul 9.

7.

Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.

van der Meer FJ, Velthorst E; Genetic Risk and Outcome of Psychosis (GROUP) Investigators.

Psychol Med. 2015 Jul;45(9):1977-88. doi: 10.1017/S0033291714003092. Epub 2015 Feb 5.

PMID:
25654244
8.

Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.

Cooper K, Chatters R, Kaltenthaler E, Wong R.

Health Technol Assess. 2015 Jul;19(56):1-130. doi: 10.3310/hta19560. Review.

9.

The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).

Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi K, Bertani M, Bissoli S, Lazzarotto L, Marrella G, Lamonaca D, Riolo R, Gardellin F, Urbani A, Tansella M, Ruggeri M; PICOS-VENETO Group.

J Psychiatr Res. 2013 Apr;47(4):438-44. doi: 10.1016/j.jpsychires.2012.11.009. Epub 2013 Jan 4.

PMID:
23290558
10.

Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.

Machielsen M, van der Sluis S, de Haan L.

Aust N Z J Psychiatry. 2010 Aug;44(8):721-8. doi: 10.3109/00048671003689710.

PMID:
20636193
11.

Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study.

González-Blanch C, Gleeson JF, Koval P, Cotton SM, McGorry PD, Alvarez-Jimenez M.

PLoS One. 2015 Apr 7;10(4):e0122404. doi: 10.1371/journal.pone.0122404. eCollection 2015.

12.

Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.

Baker AL, Hides L, Lubman DI.

J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry. Review.

PMID:
20331929
13.

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N.

BMJ. 2010 Nov 24;341:c6325. doi: 10.1136/bmj.c6325.

14.

Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.

Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ.

Addiction. 2009 Mar;104(3):378-88. doi: 10.1111/j.1360-0443.2008.02444.x.

PMID:
19207345
15.

Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.

Malcolm CP, Picchioni MM, DiForti M, Sugranyes G, Cooke E, Joseph C, McQueen G, Paparelli A, Stilo S, O'Connor J, Morgan C, Murray RM, Hodgins S.

Schizophr Res. 2011 Mar;126(1-3):81-6. doi: 10.1016/j.schres.2010.11.025. Epub 2010 Dec 24.

PMID:
21186097
16.

Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial.

Bonsack C, Gibellini Manetti S, Favrod J, Montagrin Y, Besson J, Bovet P, Conus P.

Psychother Psychosom. 2011;80(5):287-97. doi: 10.1159/000323466. Epub 2011 Jun 1.

PMID:
21646823
17.

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.

Hides L, Dawe S, Kavanagh DJ, Young RM.

Br J Psychiatry. 2006 Aug;189:137-43.

18.

The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.

Hides L, Kavanagh DJ, Dawe S, Young RM.

Drug Alcohol Rev. 2009 May;28(3):250-6. doi: 10.1080/09595230802130158.

PMID:
18608451
19.
20.

Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.

Arnold C, Allott K, Farhall J, Killackey E, Cotton S.

Schizophr Res. 2015 Oct;168(1-2):231-7. doi: 10.1016/j.schres.2015.07.051. Epub 2015 Aug 8.

PMID:
26260081

Supplemental Content

Support Center